Whole brain flow cytometry of mice treated with pmel T cells and VSV-hgp100 showed a significant increase in pmel (Thy1.1+) T cells three days after the last VSV dose, and a trend towards significance for endogenous (Thy1.1-) CD4 and CD8 T cells compared to monotherapy or untreated mice (Fig. 5 A).
← all excerpts
Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity.
1
—
—